Empiricism, Engineering & Acceleration of Drug Discovery
, Karen Akinsanya
Innovation in Clinical Development: Is it a Thing?
, Brian Alexander , Mathai Mammen , Andrew Plump , Jason Rhodes
Designing Novel RNA Medicines for the Brain
, Julia Alterman
Next-Gen Gene Editing
, Tom Barnes
Engineering the Future with Biology
, Sangeeta Bhatia , Susan Hockfield
Building a Biotech Company on Novel Biology
, Robert Blum , Marshall Urist
Antisense: Seeing the Light after a Long Tunnel
, Stan Crooke
Neuroelectronic Medicine: Two Decades of Brain Computer Interface (BCI) Development
, John Donoghue
MIT Hacks: A Rich Tradition
, Bill Doyle
RNAi: Science to Patients
, Yvonne Greenstreet , Phillip Sharp
Cell Therapy Breakthroughs
, Steve Harr
Is RNA the Key to Cancer Vaccines?
, Kyle Holen
, Ying Huang
Harnessing Natural Killer Cells for Cancer Treatment
, Tyler Jacks
Illuminating the Dark Genome
, Rosana Kapeller , Anthony Philippakis
Looking Back – and Forward – On a Career of Innovation
, Robert Langer , Amy Schulman
, David Liu
Next-Gen Payment Structures for Expensive Medicines
, Andrew Lo
Technology for Bioelectronic Medicine
, George Malliaras
Insights from Day 1
, Siddhartha Mukherjee
Oncology Regulation Themes
, Richard Pazdur , Steve Usdin
Ode to the Ribosome, and Musings on Life and Death
, Venkatraman Ramakrishnan , Brian Greene
Modern Drug Discovery from Different Perspectives
, Charles Sawyers
Modern Drug Discovery from Different Perspectives Panel
, Charles Sawyers , Robert Plenge , Angela Koehler , Karen Akinsanya
A New Generation of Integrin Medicines
, Praveen Tipirneni
Can the Immune System be Programmed?
, Bruce Walker
Next-Gen Immunology: An FcRN Blockbuster in the Making
, Sally Ward
Antibody Innovations
, Sir Gregory Winter , Siddhartha Mukherjee